IL10 and metabolic dysfunction-associated steatohepatitis: Considering separately the NASH and NO-NASH patients, we found a positive correlation between P-IL10/IL17 and AST (r = 0.72; p = 0.01) in the NO-NASH patients and a positive correlation between HV-IL10/IL17 and AST (r = 0.48; p = 0.01) in the NASH patients.